Patent Assignment
Reel/Frame 036175/0639
Assignment of Assignor's Interest
Recorded: 2015-07-24
Pages: 10
Assignor
BIOGEN IDEC MA INC.
Executed: 2011-03-31
Assignee
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Substituted 1,3-Thiazoles as Synthetic Intermediates for Preparation of Raf Kinase Inhibitors
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 24, 2015
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 036175/0586 →
Assignment of Assignor's Interest
Jul 24, 2015
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 036175/0621 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0669 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →